Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

AstraZeneca (AZN)

Add to Watchlists
Create an Alert
67.78 +0.92  +1.38% NYSE Apr 23, 8:00PM BATS Real time Currency in USD

AstraZeneca Cash from Investing (TTM):

-2.889B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Investing (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Investing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -2.889B
Sept. 30, 2013 -2.399B
June 30, 2013 -4.45B
March 31, 2013 -2.816B
Dec. 31, 2012 -1.859B
Sept. 30, 2012 -4.925B
June 30, 2012 -955.00M
March 31, 2012 -1.529B
Dec. 31, 2011 -2.022B
Sept. 30, 2011 1.106B
June 30, 2011 92.00M
March 31, 2011 -1.019B
Dec. 31, 2010 -2.226B
Sept. 30, 2010 -3.678B
June 30, 2010 -4.346B
March 31, 2010 -3.657B
Dec. 31, 2009 -2.476B
Sept. 30, 2009 -1.044B
June 30, 2009 -859.00M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

AZN Cash from Investing (TTM) Benchmarks

Companies
GlaxoSmithKline 863.67M
Pfizer -10.62B
Novartis -3.352B

AZN Cash from Investing (TTM) Range, Past 5 Years

Minimum -4.925B Sep 2012
Maximum 1.106B Sep 2011
Average -2.208B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.